JF
CLDX icon

Jump Financial’s Celldex Therapeutics CLDX Stock Holding History

Jump Financial’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$280K Sell
8,820
-136,344
-94% -$3.72M ﹤0.01% 1515
2025
Q4 		$3.94M Buy
145,164
+131,021
+926% +$3.45M 0.05% 431
2025
Q3 		$366K Sell
14,143
-15,360
-52% -$356K ﹤0.01% 1406
2025
Q2 		$600K Buy
29,503
+10,255
+53% +$200K 0.01% 1161
2025
Q1 		$349K Buy
19,248
+2,735
+17% +$61.1K 0.01% 1232
2024
Q4 		$417K Buy
+16,513
New +$449K 0.01% 1165
2023
Q1 		– Sell
-21,253
Closed -$947K – 1647
2022
Q4 		$947K Buy
+21,253
New +$759K 0.05% 506
2021
Q3 		– Sell
-51,400
Closed -$1.72M – 1142
2021
Q2 		$1.72M Buy
+51,400
New +$1.41M 0.17% 143
2021
Q1 		– Sell
-13,100
Closed -$229K – 982
2020
Q4 		$229K Buy
+13,100
New +$236K 0.04% 721

Other funds holding CLDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EP
Eversept Partners New York $1.52B AUM 121.13% 1-Year Est. Return